Eurazeo (FR:RF) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Eurazeo, in partnership with Kurma Partners, has invested in PanTera through a €93 million financing round aimed at establishing large-scale production of Actinium-225, a promising cancer-fighting radioisotope. This investment marks Eurazeo’s second Growth Equity investment and reinforces its commitment to healthcare innovation in Europe. PanTera plans to significantly increase production to support 100,000 patients annually by 2029, contributing to European medical sovereignty and access to healthcare.
For further insights into FR:RF stock, check out TipRanks’ Stock Analysis page.